Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

Chief Financial Officer

President and CEO

See Remarks

Chief Technology Officer

Chief Medical Officer

Senior VP, Drug Discovery

Interim CFO

Wave Life Sciences Ltd., a clinical-stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid (RNA) to correct disease-causing mutations, modulate protein activity, restore the production of functional proteins, or reduce the expression of disease-promoting RNAs or proteins. The company also develops WVE-004, a C9orf72 molecule for the treatment of amyotrophic lateral sclerosis and frontotemporal dementia; WVE-003, a mutant huntingtin SNP3 molecule for the treatment of Huntington's disease; WVE-N531, an Exon 53 molecule for the treatment of Duchenne muscular dystrophy; WVE-006, the SERPINA1 molecule for the treatment of Alpha-1 antitrypsin deficiency (AATD); and ATXN3, a discovery stage program for the treatment of spinocerebellar ataxia 3, as well as multiple preclinical programs for CNS disorders, including Alzheimer's and Parkinson's diseases. It has collaboration agreements with Pfizer Inc., Takeda Pharmaceutical Company Limited, and Glaxo Group Limited. The company was incorporated in 2012 and is based in Singapore.

Wave Life Sciences Ltd., a clinical-stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides thr...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-04-03	Premium	sold	Premium	Premium	Premium	Chief Financial Officer
2023-12-11	Premium	bought	Premium	Premium	Premium	-
2023-12-07	Premium	bought	Premium	Premium	Premium	-
2023-08-23	Premium	sold	Premium	Premium	Premium	Chief Financial Officer
2023-02-16	Premium	sold	Premium	Premium	Premium	President and CEO
2023-02-16	Premium	sold	Premium	Premium	Premium	See Remarks
2023-02-16	Premium	sold	Premium	Premium	Premium	See Remarks
2023-02-16	Premium	sold	Premium	Premium	Premium	Chief Financial Officer
2022-06-16	Premium	bought	Premium	Premium	Premium	-
2022-05-05	Premium	sold	Premium	Premium	Premium	Chief Financial Officer
2022-05-05	Premium	sold	Premium	Premium	Premium	President and CEO
2022-05-05	Premium	sold	Premium	Premium	Premium	See Remarks
2022-05-05	Premium	sold	Premium	Premium	Premium	See Remarks
2022-05-05	Premium	sold	Premium	Premium	Premium	See Remarks
2022-05-04	Premium	acquired	Premium	Premium	Premium	See Remarks
2022-05-04	Premium	acquired	Premium	Premium	Premium	See Remarks
2022-05-04	Premium	acquired	Premium	Premium	Premium	See Remarks
2022-05-04	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2022-05-04	Premium	acquired	Premium	Premium	Premium	President and CEO
2022-02-16	Premium	sold	Premium	Premium	Premium	Chief Financial Officer
2022-02-16	Premium	sold	Premium	Premium	Premium	See Remarks
2022-02-16	Premium	sold	Premium	Premium	Premium	Chief Technology Officer
2022-02-16	Premium	sold	Premium	Premium	Premium	See Remarks
2022-02-16	Premium	sold	Premium	Premium	Premium	President and CEO

WVE - WaVe Life Sciences Ltd Stock Price, Fair Value and News

Latest Insider Trading transactions for WVE